Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FY1G5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,709
Award facts
- Contract value 100% obligated
- $1,709.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dupixent 300 mg/2 mL pen injections. The contract, valued at $1,709.46 with a firm fixed price structure, represents a non-set-aside competitive award. Performance will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio under its DLA prime contract encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Dupixent, a biologic treatment for conditions such as eczema and asthma, represents part of the company's comprehensive pharmaceutical support for defense healthcare programs. The delivery order structure enables the DLA to procure medical commodities as needed while maintaining pricing stability through the firm fixed price arrangement.
Quick answers
Who was awarded contract SPE2DB26FY1G5?
SPE2DB26FY1G5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FY1G5 worth?
The government has obligated $1,709 on SPE2DB26FY1G5.
Is contract SPE2DB26FY1G5 an order under another contract?
Yes. SPE2DB26FY1G5 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1G5 competed?
The extent of competition for SPE2DB26FY1G5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award